Association For Research In Vision And Ophthalmology Research Articles

Efficacy and Tolerability of Nonpenetrating Filtering Surgery With and Without Implant in Treatment of Open Angle Glaucoma

To evaluate the efficacy and tolerability of nonpenetrating filtering surgery augmented with implant (NPFSI) compared with nonpenetrating filtering surgery without implant (NPFS) in the treatment of patients with open angle glaucoma. Pertinent studies were selected through extensive searches of the Cochrane Library, PubMed, Embase, and American Association of Ophthalmology (AAO) and Association for Research in Vision and Ophthalmology (ARVO) meeting abstracts. Seven controlled clinical trials meeting the predefined criteria were systematically reviewed by meta-analysis. The main outcome measures were percentage intraocular pressure (IOP) reduction, complete success rates, and qualified success rates. The pooled estimates were carried out in RevMan version 4.2 software. The weighted mean difference of the percentage IOP reduction from baseline were 6.7% (95% confidence intervals: -3.8 to 17.2) when comparing NPFSI with NPFS. NPFSI was associated with numerically greater, but nonsignificant, IOP lowering efficacy than NPFS. The pooled risk differences comparing NPFSI with NPFS were 0.13 (-0.02 to 0.28) in complete success rate and 0.09 (-0.04 to 0.21) in qualified success rate. Numerically greater, but nonsignificant, proportions of NPFSI patients than NPFS patients achieved the target end point IOP. NPFSI resulted in the same incidences of postoperative complications as NPFS. NPFSI was associated with equivalent efficacy to standard NPFS in lowering IOP. Comparable proportions of patients reached the IOP target with NPFSI and NPFS. Both surgeries were well tolerated.

Highlights from the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2009

Highlights from the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2009

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) Fort Lauderdale, April 27-May 1, 2008

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) Fort Lauderdale, April 27-May 1, 2008

ARVO Annual Meeting 2008: Visual Prostheses Research

The first visual prostheses were conceived approximately 40 years ago, but interest in the field of artificial vision has particularly increased over the last 10–15 years. Recent progress in microtechnology has made it possible to envision extremely small and highly integrated neurostimulators dedicated to restoring some useful vision to blind patients. A number of research groups – essentially multidisciplinary consortia – are presently working on projects aiming at the development of a visual prosthesis stimulating either surviving retinal neurons, fibers of the optic nerve or the visual cortex itself. The annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) is one of the largest ophthalmic research events and provides an excellent update of current work. Approximately 15 years ago, research on visual prostheses was practically unreported at ARVO. Nowadays, there are numerous presentations and several sessions on the topic. At this year’s ARVO meeting, artificial vision was introduced in the ‘Innovations in restoring vision’ paper session on the first day. Over the following days, four sessions (two poster and two paper sessions, totaling 67 presentations) were dedicated to visual prostheses. The aim of this report is to summarize these presentations. The numbers in brackets refer to ARVO program numbers.

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) Fort Lauderdale, Florida May 6-10, 2007

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) Fort Lauderdale, Florida May 6-10, 2007

Fortschritte in der Diagnose und Therapie von Erkrankungen der Augenoberfläche: Trockenes Auge und okuläre Allergien

The 77th meeting of the Association for Research in Vision and Ophthalmology (ARVO) presented the latest developments in clinical research and practice across a range of ophthalmic disciplines. Of particular interest was the current status of research in dry eye and ocular allergy. With these conditions being very common to ophthalmologists, and the fact that they are difficult to differentiate due to the number of overlapping symptoms, there remains a need for more rapid and accurate methods for their diagnosis. Therefore, a number of new tools were presented that have the potential for use in clinical trials and practice to improve the diagnosis and assessment of dry eye and ocular allergy. Some of these tools have been developed based on a greater understanding of the pathophysiology of dry eye and ocular allergy, and the various molecular pathways involved. Indeed, a greater understanding of the molecular mechanisms involved in the pathogenesis of dry eye and ocular allergy has identified potential targets for the treatment of these conditions. Continuing research into new agents can provide ophthalmologists with a number of options that will ultimately benefit the patient.

Acta Ophthalmologica for EVER

<i>Acta Ophthalmologica</i> for EVER

The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Florida, May 1-4, 2005

The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Florida, May 1-4, 2005

Effects of oxygen and carbon dioxide on human retinal circulation: an investigation using blue field simulation and scanning laser ophthalmoscopy

To investigate the quantitative response of retinal circulation in normal human eyes to oxygen and carbon dioxide provocation and to gain more information about retinal mean transit time (MTT). Healthy subjects were studied while breathing: room air (O(2) baseline); pure O(2); room air (CO(2) baseline), and CO(2) in room air. The CO(2) level was brought to 30% above individual baseline level. During each gas exposure, blue field simulation was used to estimate the velocity of macular leucocytes and fluorescein angiography was used to determine MTT, arteriovenous passage time (AVP) and vessel diameters. Breathing pure O(2) caused a reduction in macular leucocyte velocity of about 13%, a non-significant change in MTT and AVP from baseline, and a 10% reduction in the diameter of temporal retinal arteries and veins. Breathing CO(2) caused an increase in macular leucocyte velocity of 21%, a non-significant change in MTT and AVP, and no change in retinal vascular diameters. Both O(2) and CO(2) had the expected effects on retinal blood flow, as judged by leucocyte velocity in the macular capillaries, but little effect on retinal MTT, indicating concomitant changes in flow and retinal vascular volume. Measuring the diameter of retinal vessels before and during pure O(2) breathing is a simple and effective way of determining the reactivity of retinal vessels.

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Florida, May 4???9, 2003

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Florida, May 4???9, 2003

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Florida, May 5-10, 2002.

Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Florida, May 5-10, 2002.

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, April 29???May 4, 2001

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, April 29???May 4, 2001

In memoriam: A. Edward Maumenee, Jr., MD 1913–1998

In memoriam: A. Edward Maumenee, Jr., MD 1913–1998

The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting